ClinicalTrials.gov
ClinicalTrials.gov Menu

Tasimelteon for the Treatment of Non-24-hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01429116
Recruitment Status : Completed
First Posted : September 5, 2011
Last Update Posted : April 21, 2015
Sponsor:
Information provided by (Responsible Party):
Vanda Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : January 2015
  Actual Study Completion Date : January 2015